BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23575266)

  • 1. IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA.
    Klöhn PC; Wuellner U; Zizlsperger N; Zhou Y; Tavares D; Berger S; Zettlitz KA; Proetzel G; Yong M; Begent RH; Reichert JM
    MAbs; 2013; 5(2):178-201. PubMed ID: 23575266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.
    Nilvebrant J; Dunlop DC; Sircar A; Wurch T; Falkowska E; Reichert JM; Helguera G; Piccione EC; Brack S; Berger S
    MAbs; 2012; 4(2):153-81. PubMed ID: 22453091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.
    Arnett SO; Teillaud JL; Wurch T; Reichert JM; Dunlop C; Huber M
    MAbs; 2011; 3(2):133-52. PubMed ID: 21304271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.
    Marquardt J; Begent RH; Chester K; Huston JS; Bradbury A; Scott JK; Thorpe PE; Veldman T; Reichert JM; Weiner LM
    MAbs; 2012; 4(6):648-52. PubMed ID: 23007482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.
    Parren PW; Burton DR; Bradbury A; Huston JS; Carter PJ; Veldman T; Chester KA; Larrick JW; Alfenito MR; Scott JK; Weiner LM; Adams GP; Reichert JM
    MAbs; 2015; 7(6):981-8. PubMed ID: 26421752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.
    Pauthner M; Yeung J; Ullman C; Bakker J; Wurch T; Reichert JM; Lund-Johansen F; Bradbury AR; Carter PJ; Melis JP
    MAbs; 2016; 8(3):617-52. PubMed ID: 26909869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.
    Larrick JW; Alfenito MR; Scott JK; Parren PW; Burton DR; Bradbury AR; Lemere CA; Messer A; Huston JS; Carter PJ; Veldman T; Chester KA; Schuurman J; Adams GP; Reichert JM
    MAbs; 2016; 8(8):1425-1434. PubMed ID: 27557809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.
    Larrick JW; Parren P; Huston JS; Plückthun A; Bradbury A; Tomlinson IM; Chester KA; Burton DR; Adams GP; Weiner LM; Scott JK; Alfenito MR; Veldman T; Reichert JM
    MAbs; 2014; 6(5):1115-23. PubMed ID: 25517297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.
    Almagro JC; Gilliland GL; Breden F; Scott JK; Sok D; Pauthner M; Reichert JM; Helguera G; Andrabi R; Mabry R; Bléry M; Voss JE; Laurén J; Abuqayyas L; Barghorn S; Ben-Jacob E; Crowe JE; Huston JS; Johnston SA; Krauland E; Lund-Johansen F; Marasco WA; Parren PW; Xu KY
    MAbs; 2014; 6(3):577-618. PubMed ID: 24589717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IBC's conference on antibody engineering; new technology, application and commercialisation.
    Wilton J; Braddock P; Smith S; Smith S
    Expert Opin Investig Drugs; 1998 May; 7(5):835-8. PubMed ID: 15991973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody engineering--IBC's 15th Annual International Conference. 30 November-3 December 2004, San Diego, CA, USA.
    Haurum JS
    IDrugs; 2005 Feb; 8(2):91-3. PubMed ID: 15696403
    [No Abstract]   [Full Text] [Related]  

  • 12. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
    Gu J; Ghayur T
    Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.
    Muda M; Gross AW; Dawson JP; He C; Kurosawa E; Schweickhardt R; Dugas M; Soloviev M; Bernhardt A; Fischer D; Wesolowski JS; Kelton C; Neuteboom B; Hock B
    Protein Eng Des Sel; 2011 May; 24(5):447-54. PubMed ID: 21498564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.
    Lugovskoy AA; Reichert JM; Beck A
    MAbs; 2012; 4(2):134-52. PubMed ID: 22453093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, France.
    Pauwels PJ; Dumontet C; Reichert JM; Beck A; Goetsch L; Corvaia N; Klein C; Coiffier B; Teicher B
    MAbs; 2012; 4(4):434-44. PubMed ID: 22684281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.
    Michaelson JS; Demarest SJ; Miller B; Amatucci A; Snyder WB; Wu X; Huang F; Phan S; Gao S; Doern A; Farrington GK; Lugovskoy A; Joseph I; Bailly V; Wang X; Garber E; Browning J; Glaser SM
    MAbs; 2009; 1(2):128-41. PubMed ID: 20061822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational engineering of antibody therapeutics targeting multiple oncogene pathways.
    Fitzgerald J; Lugovskoy A
    MAbs; 2011; 3(3):299-309. PubMed ID: 21393992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homogeneously modified immunoglobulin domains for therapeutic application.
    Liu T; Du J; Luo X; Schultz PG; Wang F
    Curr Opin Chem Biol; 2015 Oct; 28():66-74. PubMed ID: 26117722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next generation antibody drugs: pursuit of the 'high-hanging fruit'.
    Carter PJ; Lazar GA
    Nat Rev Drug Discov; 2018 Mar; 17(3):197-223. PubMed ID: 29192287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USA.
    Ho M; Royston I; Beck A
    MAbs; 2012; 4(5):562-70. PubMed ID: 22864478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.